Aptar Pharma

By Dave Muoio 02:54 pm April 22, 2020
Real-world evidence platforms Aetion and HealthVerity are playing to their strengths with the joint launch of new tools to support biopharmas and regulators gauging new COVID-19 treatments. The first, called the Real-Time Evidence Platform, is built on an instance of Aetion's platform and focuses on up-to-date usage, safety and effectiveness data. The Real-Time Trend Reporting and Interactive...
By Dave Muoio 04:03 pm May 30, 2018
Today, Madison, Wisconsin-based digital respiratory health company Propeller Health announced a $20 million funding round led by a $10 million investment from Aptar Pharma. Existing investors Safeguard Scientifics, Social Capital, Hikma Ventures, 3M Ventures, and SR One comprised the other half of the round. According to a release, the new funding will be invested into the company’s digital...
By Jonah Comstock 05:03 pm May 5, 2017
Crystal Lake, Illinois-based Aptar Pharma is teaming up with digital health startup Kali Care to develop a new way of measuring adherence to eye drops in clinical trials.  Because they are somewhat onerous to use, eye drops have even lower rates of adherence than other medications. Kali Care, based in Silicon Valley, makes a small sensor that can be installed in a container for eye drop...
By Jonah Comstock 04:44 pm March 23, 2016
Propeller Health and Boehringer Ingelheim announced a new commercial partnership. Under the partnership, COPD and asthma patients using Boehringer's Respimat inhaler will have the opportunity to enroll in a program at select health systems that will monitor their adherence via a Propeller sensor and improve their engagement in their health.  "So far we have developed a popular Bluetooth-enabled...
By Jonah Comstock 05:41 pm February 24, 2016
Propeller Health is partnering with Aptar Pharma, a drug delivery system company, to create what the company believes will be the first-to-market integrated, connected metered dose inhaler (MDI). "Patients and physicians deserve better designed inhalers that are easier to use and help them successfully treat their chronic respiratory disease,” David Van Sickle, CEO of Propeller, said in a...